3.8 Review

Progressive osseous heteroplasia: diagnosis, treatment, and prognosis

期刊

APPLICATION OF CLINICAL GENETICS
卷 8, 期 -, 页码 37-47

出版社

DOVE MEDICAL PRESS LTD
DOI: 10.2147/TACG.S51064

关键词

progressive osseous heteroplasia; GNAS; heterotopic ossification

资金

  1. National Institutes of Health [R01-AR046831]
  2. Progressive Osseous Heteroplasia Association
  3. Italian POH Association
  4. International Fibrodysplasia Ossificans Progressiva Association
  5. University of Pennsylvania Center for Research in FOP and Related Disorders
  6. Isaac and Rose Nassau Professorship of Orthopaedic Molecular Medicine
  7. Cali/Weldon Professorship
  8. NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046831] Funding Source: NIH RePORTER

向作者/读者索取更多资源

Progressive osseous heteroplasia (POH) is an ultrarare genetic condition of progressive ectopic ossification. Most cases of POH are caused by heterozygous inactivating mutations of GNAS, the gene encoding the alpha subunit of the G-stimulatory protein of adenylyl cyclase. POH is part of a spectrum of related genetic disorders, including Albright hereditary osteodystrophy, pseudohypoparathyroidism, and primary osteoma cutis, that share common features of superficial ossification and association with inactivating mutations of GNAS. The genetics, diagnostic criteria, supporting clinical features, current management, and prognosis of POH are reviewed here, and emerging therapeutic strategies are discussed.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

3.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据